drugset / Trial / NCT00573157
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to learn whether atacicept treatment leads to improvement in kidney function in subjects with active lupus nephritis in combination with mycophenolate mofetil (MMF) and corticosteroids. The study was sponsored by Merck Serono International; operational oversight was provided by ZymoGenetics.
Timeline
- Start
- 2007-12
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atacicept | Protein / enzyme biologic | 150 mg | Subcutaneous |
| Background | Mycophenolate Mofetil | Small molecule | 1500 mg | Oral |
| Background | Prednisone | Other / unclassified | 7.5 mg | — |
| Background | Prednisone | Other / unclassified | 10 mg | — |